13F HOLDINGS REPORT
Bain Capital Life Sciences Investors, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000950123-23-002178
Total Value
$894,849
Positions
33
Other Managers
11
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 4,831,307 | $125,662 | 14.04% |
| 2 | NUVALENT INC | NUVL | 3,577,267 | $106,531 | 11.90% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 8,300,000 | $90,470 | 10.11% |
| 4 | NATERA INC | NTRA | 1,400,000 | $56,238 | 6.28% |
| 5 | MERSANA THERAPEUTICS INC | 59045L106 | 8,663,673 | $50,769 | 5.67% |
| 6 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 3,000,000 | $44,400 | 4.96% |
| 7 | CRINETICS PHARMACEUTICALS IN | CRNX | 2,305,558 | $42,192 | 4.71% |
| 8 | DYNAVAX TECHNOLOGIES CORP | 268158201 | 3,915,000 | $41,656 | 4.66% |
| 9 | PHARVARIS N V | PHVS | 3,180,601 | $35,782 | 4.00% |
| 10 | CARA THERAPEUTICS INC | 140755109 | 2,696,030 | $28,955 | 3.24% |
| 11 | PROTAGONIST THERAPEUTICS INC | PTGX | 2,364,410 | $25,796 | 2.88% |
| 12 | ANNEXON INC | ANNX | 4,886,616 | $25,264 | 2.82% |
| 13 | EQRX INC | 26886C107 | 10,003,573 | $24,609 | 2.75% |
| 14 | CTI BIOPHARMA CORP | 12648L601 | 3,777,308 | $22,702 | 2.54% |
| 15 | NURIX THERAPEUTICS INC | NRIX | 1,822,883 | $20,015 | 2.24% |
| 16 | SAVARA INC | SVRA | 11,622,598 | $18,015 | 2.01% |
| 17 | SOLID BIOSCIENCES INC | SLDB | 3,130,422 | $16,842 | 1.88% |
| 18 | TANGO THERAPEUTICS INC | TNGX | 1,921,790 | $13,933 | 1.56% |
| 19 | 2SEVENTY BIO INC | 901384107 | 1,408,901 | $13,201 | 1.48% |
| 20 | X4 PHARMACEUTICALS INC | XFOR | 12,202,510 | $12,117 | 1.35% |
| 21 | ATEA PHARMACEUTICALS INC | AVIR | 2,485,638 | $11,956 | 1.34% |
| 22 | ACADIA PHARMACEUTICALS INC | ACAD | 701,402 | $11,166 | 1.25% |
| 23 | C4 THERAPEUTICS INC | CCCC | 1,642,210 | $9,689 | 1.08% |
| 24 | RAPID MICRO BIOSYSTEMS INC | RPID | 8,434,560 | $9,531 | 1.07% |
| 25 | SYROS PHARMACEUTICALS INC | 87184Q206 | 2,124,694 | $7,628 | 0.85% |
| 26 | XILIO THERAPEUTICS INC | XLO | 2,805,413 | $7,547 | 0.84% |
| 27 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 1,431,058 | $5,696 | 0.64% |
| 28 | THIRD HARMONIC BIO INC | 88427A107 | 1,151,657 | $4,952 | 0.55% |
| 29 | NAUTILUS BIOTECHNOLOGY INC | NAUT | 2,000,000 | $3,600 | 0.40% |
| 30 | INVIVYD INC | IVVD | 1,937,207 | $2,906 | 0.32% |
| 31 | APTINYX INC | 03836N103 | 8,891,758 | $2,537 | 0.28% |
| 32 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 5,347,689 | $2,406 | 0.27% |
| 33 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 100,000 | $86 | 0.01% |